Pheochromocytoma and tetralogy of Fallot: a rare but potentially dangerous combination.

OBJECTIVE To describe a case of pheochromocytoma (PHEO) with tetralogy of Fallot (TOF) and discuss the difficulties encountered during the management of this patient, with a review of the literature. METHODS We report the clinical course, imaging, and management issues of our patient and review relevant literature. RESULTS A 14-year-old female who was known to have TOF presented with classical paroxysmal symptoms and worsening dyspnea. She was diagnosed as having epinephrine-secreting PHEO based on biochemical, radiologic, and functional imaging. She was treated with an α-1 blocker for control of paroxysms but developed severe cyanotic spells. She required addition of a calcium-channel blocker for control of the paroxysms and underwent successful cardiac repair. CONCLUSION Treatment of the combination of cyanotic congenital heart disease (CCHD) and PHEO requires an individualized and multidisciplinary approach with judicious use of available medications. This is the first case of uncorrected TOF and epinephrine-secreting PHEO. Our case also reiterates the need for further studies to better understand the pathophysiologic link between PHEO/paraganglioma and CCHD.

[1]  B. Tang,et al.  Two novel functional single nucleotide polymorphisms of ADRB3 are associated with type 2 diabetes in the Chinese population. , 2013, The Journal of clinical endocrinology and metabolism.

[2]  Hyun-Young Kim,et al.  Extra-adrenal pheochromocytoma after operation of congenital heart disease: a case report of 18-year-old boy , 2012, Journal of the Korean Surgical Society.

[3]  K. Pacak,et al.  Pheochromocytoma and paraganglioma. , 2010, Progress in brain research.

[4]  R. Sinha,et al.  Pentalogy of Fallot and cardiac paraganglioma: a case report , 2009, Cases journal.

[5]  F. McGowan,et al.  The perioperative management of a patient with Fontan physiology for pheochromocytoma resection. , 2008, Journal of cardiothoracic and vascular anesthesia.

[6]  D. Spevack,et al.  Single left ventricle and pheochromocytoma. , 2008, Congenital heart disease.

[7]  P. Luke,et al.  Case report: Retroperitoneoscopic pheochromocytoma removal in an adult with Eisenmenger’s syndrome , 2008, Canadian journal of anaesthesia = Journal canadien d'anesthesie.

[8]  R. Horikawa,et al.  A case of malignant pheochromocytoma with Holt-Oram syndrome. , 2008, Endocrine journal.

[9]  K. Pacak Preoperative management of the pheochromocytoma patient. , 2007, The Journal of clinical endocrinology and metabolism.

[10]  X. Capdevila,et al.  Transpulmonary thermodilution hemodynamic monitoring for pheochromocytoma surgery in a child with complex congenital heart disease , 2006, Paediatric anaesthesia.

[11]  F. McGowan,et al.  The perioperative management of a patient with complex single ventricle physiology and pheochromocytoma. , 2005, Anesthesia and analgesia.

[12]  Y. Asada,et al.  Two cases of pheochromocytoma associated with tetralogy of Fallot. , 2003, Hypertension research : official journal of the Japanese Society of Hypertension.

[13]  O. K. Hansen,et al.  Tetralogy of Fallot. A population-based study of epidemiology, associated malformations and survival in western Denmark 1984-1992. , 1999, Scandinavian cardiovascular journal : SCJ.

[14]  T. Tamai,et al.  Effectiveness of long-acting nifedipine in pheochromocytoma. , 1989, Japanese heart journal.

[15]  Hutchins Gm,et al.  Peripheral neuroblastic tumors and congenital heart disease: Possible role of hypoxic states in tumor induction , 1985 .

[16]  J. L. Reynolds,et al.  Congenital heart disease and pheochromocytoma. , 1966, American journal of diseases of children.

[17]  W. Roberts,et al.  Cyanotic Malformations of the Heart with Pheochromocytoma: A Report of Five Cases , 1964, Circulation.